- BusinessYahoo Finance
A nationwide closure would be crushing for the company, crippling its distribution network amid a spike in demand for Amazon’s delivery service.
“This isn’t a class on literature. This is a captain of a massive ship that’s nuclear-powered. He shouldn’t be talking that way in a letter," Trump said of Brett Crozier.
(Bloomberg) -- Russian President Vladimir Putin’s shipment of medical equipment to help the U.S. fight the coronavirus epidemic may have contained a hidden message from the Kremlin.Included in the aid appear to be ventilators produced by a firm under U.S. sanctions, according to video of the plane’s unloading at New York’s JFK airport posted by Russian state-owned news agency Ruptly.Among the boxes were Avanta M ventilators, produced by a subsidiary of KRET, which has been on the Treasury’s Specially Designated Nationals list since 2014, when Russia annexed Crimea from Ukraine. RBC newspaper first reported the connection.Even if the ventilators were not purchased directly from KRET, sanctions generally prevent importing anything that an SDN has a property interest in, according to Brian O’Toole, a former senior adviser in Treasury’s sanctions unit and now a senior fellow at the Atlantic Council.“This is another example of Putin playing the U.S.,” O’Toole said by phone. “While there are no real consequences for the government violating its own sanctions, it looks stupid for them to be breaking their own rules.”A spokeswoman for the KRET subsidiary, based near Yekaterinburg almost 900 miles east of Moscow, referred all questions to the Industry and Trade Ministry. The ministry did not respond to calls or an emailed query.While the aid was billed as a humanitarian shipment, the cost of the shipment was split evenly between U.S. companies and the Kremlin’s sovereign wealth fund. The Russian Direct Investment Fund is subject to sectoral sanctions, which prohibit it from most borrowing in the U.S. but don’t prevent it from doing business with American entities.Despite the tensions between Moscow and Washington, Putin and President Donald Trump enjoy a warm relationship. The leaders agreed on the aid during a March 30 phone call during which they also discussed the collapse of oil prices.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
In his new memoir, I'm Your Huckleberry, Val Kilmer says that he hasn't had a girlfriend in 20 Years: 'I am lonely part of every day'
As the number of coronavirus cases remains on the rise, researchers at the University of Pittsburgh School of Medicine and UPMC are working on a possible vaccine for SARS-CoV-2, the virus that causes COVID-19. Scientists announced news of the potential vaccine, which has now been tested successfully on mice, on Thursday.According to a press release from UPMC and the university, “When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.” In a paper announcing the vaccine in the journal EBioMedicine, co-author Andrea Gambotto, an associate professor of surgery at the university said the researchers hope to “get this into patients as soon as possible.” Through their previous work on SARS-CoV in 2003 and MERS-CoV in 2014, researchers and scientists in that lab have learned that a spike protein is of particular importance to building immunity against the virus. Thanks to that research, Gambotto said, “We knew exactly where to fight this new virus.”The announcement comes as we enter the fourth month of the pandemic, with one-third of the global population now on lockdown trying to fight the spread of the virus through social distancing. While that strategy is working to flatten the curve in places that adopted the practice early on, the full effects of the virus are yet to be seen in places that waited to enforce stay-at-home orders. The novel coronavirus has now infected more than one million people globally and killed more than 54,000 people. The U.S. alone has reported more than 245,500 of those cases, with hotbeds for the virus in New Orleans, Chicago, New York, Seattle, and Detroit. Still, even as we take the necessary social precautions to slow the spread of coronavirus, only a vaccine can help people build immunity to it and prevent people from getting sick. There are currently at least 35 companies and academic institutions working to do so, four of which have developed vaccines that are in the animal-testing stages, The Guardian reports. Last month, researchers at the University of Pittsburgh estimated it could take at least a year to 18 months to develop a vaccine and get through the trial period. According to Louis Falo, a professor and chairman of the Department of Dermatology at the University of Pittsburgh who co-authored the paper in EBioMedicine, they would like to start clinical trials in about a month, “give or take. Maybe two months. We just started the process.”Like what you see? How about some more R29 goodness, right here?I Tested The New Coronavirus VaccineThe C3 Test Can Diagnose People Without SymptomsCDC To Change Their Face Mask Recommendations
- U.S.Town and Country Videos
Two members of the Kennedy family, Maeve Kennedy Townsend McKean and her 8-year-old son Gideon Joseph Kennedy McKean, have drowned near Annapolis, Md. According to the Washington Post, Maeve's husband, David, confirmed that his wife and son were canoeing on the Chesapeake Bay Thursday and had not been seen since.
- LifestyleCar and Driver
View Photos of the 2021 Rivian R1SFrom Car and Driver